NCT02156960

Changes of Bone Metabolic Markers and Bone Mineral Density After Denosumab and/or Teriparatide Treatment in Japanese Osteoporotic Patients

• Status: Unknown
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: Shinshu University · Academic / Other
• Sex: All
• Age: 1 Year – 120 Years
• Healthy volunteers: Accepted

Summary

It has not been well known about the changes of bone metabolic markers, bone mineral density and other bone-related markers after teriparatide and/or denosumab treatment in Japanese osteoporotic patients.

Conditions

• Osteoporosis

Interventions

Type	Name	Description
DRUG	Denosumab treatment in osteoporotic patients	To examine the effectiveness of denosumab in osteoporotic patients
DRUG	Teriparatide treatment in osteoporotic patients	To examine the effectiveness of teriparatide in osteoporotic patients
DRUG	Denosumab and teriparatide treatment in osteoporotic patients	To examine the effectiveness of denosumab and teriparatide in osteoporotic patients

Timeline

• Start date: 2014-05-01
• Primary completion: 2015-05-01
• Completion: 2022-11-01
• First posted: 2014-06-05
• Last updated: 2020-10-22

Locations

1 site across 1 country: Japan